The positive prognostic influence of EP3 in breast cancer is surprising insofar, as both COX-2 overexpression and PGE2 elevation have been shown to have pro-tumorigenic effects in breast cancer, and EP3 is part of the signaling pathway of PGE2 and is therefore mediating PGE2 effects. This evidence concerns the gene PTGER3 and breast carcinoma.